Covid-19 could become like common cold in future, study suggests

The novel coronavirus responsible for Covid-19 could cause no more than common cold-like coughs and sniffles within the next decade, according to a study

Covid patient, coronavirus patient
Press Trust of India New Delhi
3 min read Last Updated : May 21 2021 | 1:55 PM IST

The novel coronavirus responsible for COVID-19 could cause no more than common cold-like coughs and sniffles within the next decade, according to a study.

The research, published in the journal Viruses, makes this likely prediction based on mathematical models that incorporate lessons learned from the current pandemic on how our body's immunity changes over time.

"This shows a possible future that has not yet been fully addressed," said Fred Adler, a professor of mathematics and biological sciences at the University of Utah in the US.

"Over the next decade, the severity of COVID-19 may decrease as populations collectively develop immunity," Adler said.

The study suggests that changes in the disease could be driven by adaptations of our immune response rather than by changes in the virus itself.

Although the SARS-CoV-2 virus is the best-known member of the family, other seasonal coronaviruses circulate in the human population, and they are less dangerous.

The researchers noted that some evidence indicates that one of these cold-causing relatives might have once been severe, giving rise to the "Russian flu" pandemic in the late 19th century.

The parallels led the scientists to wonder whether the severity of SARS-CoV-2 could similarly lessen over time.

They built mathematical models incorporating evidence on the body's immune response to SARS-CoV-2.

Analysing several scenarios and their versions set up a situation where an increasing proportion of the population will become predisposed to mild disease over the long term.

"In the beginning of the pandemic, no one had seen the virus before. Our immune system was not prepared," Adler explained.

The models show that as more adults become partially immune, whether through prior infection or vaccination, severe infections all but disappear over the next decade, the researchers said.

Eventually, the only people who will be exposed to the virus for the first time will be children who are naturally less prone to severe disease, they said.

"The novel approach here is to recognise the competition taking place between mild and severe COVID-19 infections and ask which type will get to persist in the long run," said Alexander Beams, study first author and graduate student at University of Utah.

"We have shown that mild infections will win, as long as they train our immune systems to fight against severe infections," Beams said.

However, the researchers noted that the models do not account for every potential influence on disease trajectory.

For instance, if new virus variants overcome partial immunity, COVID-19 could take a turn for the worse, they said.

The team also noted that these predictions will hold up only if the key assumptions of the models hold up.

"Our next step is comparing our model predictions with the most current disease data to assess which way the pandemic is going as it is happening," Adler added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: May 21 2021 | 1:53 PM IST

Next Story